Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Cash (2020 - 2025)

Historic Change in Cash for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to -$157.0 million.

  • Cellebrite DI's Change in Cash fell 37659.12% to -$157.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$69.7 million, marking a year-over-year decrease of 217981.49%. This contributed to the annual value of -$69.7 million for FY2025, which is 217981.49% down from last year.
  • Per Cellebrite DI's latest filing, its Change in Cash stood at -$157.0 million for Q4 2025, which was down 37659.12% from $102.3 million recorded in Q3 2025.
  • Cellebrite DI's 5-year Change in Cash high stood at $102.3 million for Q3 2025, and its period low was -$157.0 million during Q4 2025.
  • For the 5-year period, Cellebrite DI's Change in Cash averaged around -$441250.0, with its median value being $8.8 million (2021).
  • Per our database at Business Quant, Cellebrite DI's Change in Cash soared by 1804049.3% in 2023 and then plummeted by 69670.62% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Change in Cash stood at $36.2 million in 2021, then plummeted by 99.21% to $284000.0 in 2022, then surged by 18040.49% to $51.5 million in 2023, then grew by 10.15% to $56.7 million in 2024, then plummeted by 376.59% to -$157.0 million in 2025.
  • Its last three reported values are -$157.0 million in Q4 2025, $102.3 million for Q3 2025, and $87.0 million during Q2 2025.